An activated PI3K-Akt signaling pathway could promote GC progression by enhancing glycolysis, stabilizing mitochondrial membrane potentials, and inhibiting tumor cell apoptosis (Xu et al., 2020). The gene discussed is AKT1; the disease is neoplasm.